"Hypertension, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Descriptor ID |
D006976
|
| MeSH Number(s) |
C08.381.423
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypertension, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Hypertension, Pulmonary".
This graph shows the total number of publications written about "Hypertension, Pulmonary" by people in this website by year, and whether "Hypertension, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 4 | 3 | 7 |
| 2000 | 2 | 3 | 5 |
| 2001 | 4 | 1 | 5 |
| 2002 | 2 | 1 | 3 |
| 2003 | 5 | 1 | 6 |
| 2004 | 5 | 1 | 6 |
| 2005 | 6 | 1 | 7 |
| 2006 | 7 | 2 | 9 |
| 2007 | 2 | 3 | 5 |
| 2008 | 3 | 1 | 4 |
| 2009 | 6 | 0 | 6 |
| 2010 | 9 | 3 | 12 |
| 2011 | 10 | 7 | 17 |
| 2012 | 10 | 5 | 15 |
| 2013 | 8 | 2 | 10 |
| 2014 | 11 | 5 | 16 |
| 2015 | 9 | 4 | 13 |
| 2016 | 10 | 2 | 12 |
| 2017 | 12 | 2 | 14 |
| 2018 | 5 | 6 | 11 |
| 2019 | 14 | 3 | 17 |
| 2020 | 22 | 1 | 23 |
| 2021 | 17 | 5 | 22 |
| 2022 | 9 | 0 | 9 |
| 2023 | 14 | 1 | 15 |
| 2024 | 5 | 8 | 13 |
| 2025 | 6 | 0 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypertension, Pulmonary" by people in Profiles.
-
Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells. Arterioscler Thromb Vasc Biol. 2025 Nov; 45(11):2037-2052.
-
Procedural Variation May Contribute to 6-Minute Walk Distance Variability in Real-World Pediatric Pulmonary Arterial Hypertension Study. AAPS J. 2025 06 27; 27(5):114.
-
The nitrofen/bisdiamine murine model of congenital diaphragmatic hernia has a pulmonary hypertension vascular phenotype consistent with human CDH. Am J Physiol Lung Cell Mol Physiol. 2025 Jul 01; 329(1):L48-L60.
-
Lethal Neonatal Pulmonary Hypertension in Trisomy 21 (T21) Likely Due to Congenital Portosystemic Shunts. Pediatr Dev Pathol. 2025 Sep-Oct; 28(5):416-419.
-
Infants With a Congenital Diaphragmatic Hernia Had Favourable Pulmonary Hypertension Outcomes at 1?Year of Age. Acta Paediatr. 2025 Jul; 114(7):1680-1690.
-
Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2025 Feb; 211(2):157-173.
-
SOX17-Associated Pulmonary Hypertension in Children: A Distinct Developmental and Clinical Syndrome. J Pediatr. 2025 Mar; 278:114422.
-
Association between Time with Open Ductus Arteriosus and Outcomes in Congenital Diaphragmatic Hernia. Neonatology. 2025; 122(2):202-209.
-
Utility of urinary NT-proBNP in congenital diaphragmatic hernia: a prospective pilot study. Pediatr Res. 2025 Jun; 97(7):2305-2311.
-
Atrial flow regulators for the treatment of pulmonary arterial hypertension: what does the future hold? Expert Rev Med Devices. 2024 Oct; 21(10):889-891.